Macrocyclics' Acquisition

Macrocyclics was acquired by Orano on October 24, 2011.

Macrocyclics is a provider in the production of chelators, chemical agents that allow for the attachment of antibodies or proteins with radioactive isotopes for the development of powerful nuclear med…

Articles about Macrocyclics' Acquisition: